<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Tuberculosis vaccine development &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/tuberculosis-vaccine-development/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 05 Nov 2025 19:20:48 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Tuberculosis vaccine development &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>MIT Study Identifies Promising Targets for Next-Generation Tuberculosis Vaccine</title>
		<link>https://bioengineer.org/mit-study-identifies-promising-targets-for-next-generation-tuberculosis-vaccine/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 05 Nov 2025 19:20:30 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Immunopeptidomics]]></category>
		<category><![CDATA[MHC class II antigens]]></category>
		<category><![CDATA[mRNA vaccine technology]]></category>
		<category><![CDATA[Mycobacterium tuberculosis antigens]]></category>
		<category><![CDATA[Tuberculosis vaccine development]]></category>
		<guid isPermaLink="false">https://bioengineer.org/mit-study-identifies-promising-targets-for-next-generation-tuberculosis-vaccine/</guid>

					<description><![CDATA[In a groundbreaking advance that could redefine tuberculosis (TB) vaccine development, researchers at the Massachusetts Institute of Technology have identified promising antigenic targets from Mycobacterium tuberculosis, the bacterium responsible for the world’s deadliest infectious disease. Utilizing cutting-edge immunopeptidomics, the team screened over 4,000 proteins to pinpoint specific peptides capable of provoking robust immune responses. This [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">292131</post-id>	</item>
	</channel>
</rss>
